Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed
The summary for the Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Food and Drug Administration, which is the U.S. government agency offering this grant.
Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed: This Cooperative Agreement represents the continuation and further expansion of well-established collaborations between the World Health Organization (WHO) and the Food and Drug Administration (FDA), in support of data-driven and science-based public health strategies and approaches that align well with FDA domestic and global goals. This cooperative agreement is expected to contribute to the knowledge base of the current food and medical products safety globally and address specific challenges in the global efforts to ensure safety of such products. Relevant strategies include: 1) developing global norms and standards; 2) articulating evidence-based policy options, including those relating to regulatory systems performance; and 3) providing technical support to national regulatory authorities and governments through systems strengthening efforts.
Federal Grant Title: | Strengthening Regulatory Systems to Improve Global Food and Medical Product Quality and Safety (U01) Clinical Trials Not Allowed |
Federal Agency Name: | Food and Drug Administration (HHS-FDA) |
Grant Categories: | Agriculture Consumer Protection Food and Nutrition |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-FD-24-014 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.103 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | March 31st, 2024 |
Original Application Deadline: | March 31st, 2024 |
Posted Date: | December 11th, 2023 |
Creation Date: | December 11th, 2023 |
Archive Date: | April 30th, 2024 |
Total Program Funding: | $750,000 |
Maximum Federal Grant Award: | $750,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | December 20th, 2023 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Only the following organization is eligible to apply:The World Health Organization (WHO)Foreign InstitutionsNon-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.
- Grant Announcement Contact
- Zahara Graves
Grantor
Work - Similar Government Grants
- • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...
- • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...
- • Animal and Veterinary Innovation Centers (U18)
- • Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food...
- • Minor Use Minor Species Development of Drugs (R01)
- • Support for Small Scientific Conference Grant Program
- • Cooperative Agreement to Support the World Health Organization (WHO) International Program...
- • Clinical Studies of Safety and Effectiveness of Orphan Products
- More Grants from the Food and Drug Administration
- • Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical T...
- • Single Source Cooperative Agreement to Support HPAI H5N1 Research at Cornell University (U...
- • Animal and Veterinary Innovation Centers (U18)